|
Volumn 14, Issue 5, 1996, Pages
|
Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up
a a a a a a |
Author keywords
Essential hypertension; Left ventricular hypertrophy; Midwall fractional shortening; Prognosis
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ADULT;
AGED;
ANTIHYPERTENSIVE THERAPY;
CARDIOVASCULAR RISK;
CONFERENCE PAPER;
CONTROLLED STUDY;
ECHOCARDIOGRAPHY;
FEMALE;
FOLLOW UP;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART LEFT VENTRICLE MASS;
HEART LEFT VENTRICLE PERFORMANCE;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTOR;
STATISTICAL ANALYSIS;
SYSTOLIC BLOOD PRESSURE;
ADOLESCENT;
ADULT;
AGED;
CARDIOVASCULAR DISEASES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTROPHY, LEFT VENTRICULAR;
MALE;
MIDDLE AGED;
MYOCARDIUM;
PROGNOSIS;
RISK FACTORS;
SYSTOLE;
VENTRICULAR FUNCTION, LEFT;
|
EID: 0030451543
PISSN: 09521178
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (43)
|
References (4)
|